Treatment of short bowel syndrome patients with colon-in-continuity
AssigneeNPS Allelix Corp.
InventorsElizabeth Sanguinetti, Thomas Marriott, Jennifer Lopansri, Consuelo Blosch
Life of this patent
Estimating the term…
Abstract
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
Claims20
A method for enhancing intestinal absorption in a patient with short bowel syndrome, comprising the steps of selecting for treatment a short bowel syndrome patient presenting with colon in continuity with remnant small intestine, and treating said patient with a GLP-2 receptor agonist using a dosing regimen effective to enhance intestinal absorption by said patient.
The use of a GLP-2 receptor agonist in the preparation of a medicament to treat short bowel syndrome patients presenting with colon-in-continuity, wherein the GLP-2 receptor agonist is present in an amount effective to enhance intestinal absorption by said patients.
Dependencies are inferred from the claim text.